Kathleen J. Koenigs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kathleen J. Koenigs has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Bradley J. Quade
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA
1 shared publicationDavida Md Schiff
Department of Obstetrics, Gynecology, and Reproductive Biology and the Department of Medicine, Massachusetts General Hospital, and the Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts
1 shared publicationEvan Gale
Department of Obstetrics, Gynecology, and Reproductive Biology and the Department of Medicine, Massachusetts General Hospital, and the Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts
1 shared publication- Ilona Telefus Goldfarb
Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA USA
1 shared publication Jason L. Hornick
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA
1 shared publicationJessica Gray
Department of Obstetrics, Gynecology, and Reproductive Biology and the Department of Medicine, Massachusetts General Hospital, and the Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts
1 shared publication
Latest Publications
- Open Access
- 3 October 2024
- Published by Wolters Kluwer Health in O&G Open
- Vol. 1 (4) , 37
An Alternative Approach to Low-Dose Buprenorphine Induction in Pregnancy and Postpartum
Low-dose buprenorphine induction, unlike traditional methods, does not require that individuals experience at least moderate withdrawal before initiation. This technique has been widely used and studied in the general population; however, research in pregnancy is limited. We aimed to evaluate obstetric and neonatal outcomes after low-dose buprenorphine induction. In this retrospective case series, we reviewed all cases of low-dose induction during pregnancy or within 6 weeks postpartum at an urban academic medical center over a 3-year period. Nine patients started buprenorphine using this method, and all but one completed induction. There was a high rate of treatment retention and no apparent associated adverse neonatal events. Four individuals are in sustained remission and currently parenting. Though further research is needed, low-dose buprenorphine induction appears effective in the obstetric population.
- 3 October 2024
- Published by Wolters Kluwer Health in O&G Open
- Vol. 1 (4) , 37
Open AccessAn Alternative Approach to Low-Dose Buprenorphine Induction in Pregnancy and Postpartum
Low-dose buprenorphine induction, unlike traditional methods, does not require that individuals experience at least moderate withdrawal before initiation. This technique has been widely used and studied in the general population; however, research in pregnancy is limited. We aimed to evaluate obstetric and neonatal outcomes after low-dose buprenorphine induction. In this retrospective case series, we reviewed all cases of low-dose induction during pregnancy or within 6 weeks postpartum at an urban academic medical center over a 3-year period. Nine patients started buprenorphine using this method, and all but one completed induction. There was a high rate of treatment retention and no apparent associated adverse neonatal events. Four individuals are in sustained remission and currently parenting. Though further research is needed, low-dose buprenorphine induction appears effective in the obstetric population.